Illumina Innovation Fund II GP, L.L.C., 10% Owner at Alamar Biosciences, Inc. (ALMR), bought 235,294 shares at $17.00 ($4.0M) on 2026-04-20, disclosed to the SEC on 2026-04-20.
Illumina Innovation Fund II GP, L.L.C. executed the largest insider purchase in the company's history, buying 235,294 shares at $17.00 on April 20, 2026. This significant accumulation by a major shareholder suggests confidence in the stock's recovery potential following a recent pullback.
The stock is currently trading at $22.00, sitting roughly 10.2% below its 52-week high of $24.50 but just 2.33% above its 52-week low of $21.50. Despite a modest year-to-date gain of 4.59% according to recent analysis, the shares have recently faced short-term pressure, closing at $23.01 on May 14, 2026.
The largest insider purchase in the company's history occurred on April 20, 2026, signaling strong conviction from a major shareholder. Additionally, the insider is part of a single-purchase cluster, which can indicate a strategic entry point.
The stock faces elevated short-term risk with a short interest of 2.77% of the float. Furthermore, the negative industry buying momentum over the last 90 days suggests broader sector skepticism.
Negative factors outweigh the positive ones.